These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22160733)

  • 61. Synthetic cannabinoids: the hidden side of Spice drugs.
    Pintori N; Loi B; Mereu M
    Behav Pharmacol; 2017 Sep; 28(6):409-419. PubMed ID: 28692429
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synthetic cannabinoid withdrawal: a new demand on detoxification services.
    Macfarlane V; Christie G
    Drug Alcohol Rev; 2015 Mar; 34(2):147-53. PubMed ID: 25588420
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Near-Fatal Spice Intoxication of a Toddler.
    Ruiz-Maldonado TM; Dorey A; Christensen ED; Campbell KA
    Pediatrics; 2021 Aug; 148(2):. PubMed ID: 34233919
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Therapeutic Use of Synthetic Cannabinoids: Still an OpenIssue?
    De Luca MA; Fattore L
    Clin Ther; 2018 Sep; 40(9):1457-1466. PubMed ID: 30180974
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Psychiatric sequelae of Spice, K2, and synthetic cannabinoid receptor agonists.
    Benford DM; Caplan JP
    Psychosomatics; 2011; 52(3):295. PubMed ID: 21565605
    [No Abstract]   [Full Text] [Related]  

  • 66. Synthetic cannabinoids 2015: An update for pediatricians in clinical practice.
    Castellanos D; Gralnik LM
    World J Clin Pediatr; 2016 Feb; 5(1):16-24. PubMed ID: 26862498
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The effects of synthetic cannabinoids on executive function.
    Cohen K; Kapitány-Fövény M; Mama Y; Arieli M; Rosca P; Demetrovics Z; Weinstein A
    Psychopharmacology (Berl); 2017 Apr; 234(7):1121-1134. PubMed ID: 28160034
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of outcome expectancies for synthetic cannabinoids and botanical marijuana.
    Lauritsen KJ; Rosenberg H
    Am J Drug Alcohol Abuse; 2016 Jul; 42(4):377-84. PubMed ID: 26910181
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Spice in France: mixed herbs containing synthetic cannabinoids].
    Schlatter J; Chiadmi F; Chariot P
    Ann Biol Clin (Paris); 2012; 70(4):413-22. PubMed ID: 22796613
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Synthetic Cannabinoids Phenomenon.
    Karila L; Benyamina A; Blecha L; Cottencin O; Billieux J
    Curr Pharm Des; 2016; 22(42):6420-6425. PubMed ID: 27655416
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Spice-y Kidney Failure: A Case Report and Systematic Review of Acute Kidney Injury Attributable to the Use of Synthetic Cannabis.
    Zarifi C; Vyas S
    Perm J; 2017; 21():. PubMed ID: 28488989
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Synthetic cannabinoid JWH-018 and psychosis: an explorative study.
    Every-Palmer S
    Drug Alcohol Depend; 2011 Sep; 117(2-3):152-7. PubMed ID: 21316162
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A Case of Status Epilepticus and Transient Stress Cardiomyopathy Associated with Smoking the Synthetic Psychoactive Cannabinoid, UR-144.
    Al Fawaz S; Al Deeb M; Huffman JL; Al Kholaif NA; Garlich F; Chuang R
    Am J Case Rep; 2019 Dec; 20():1902-1906. PubMed ID: 31857571
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Acute kidney injury associated with synthetic cannabinoid use--multiple states, 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Feb; 62(6):93-8. PubMed ID: 23407124
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Psychosis and severe rhabdomyolysis associated with synthetic cannabinoid use: A case report.
    Durand D; Delgado LL; de la Parra-Pellot DM; Nichols-Vinueza D
    Clin Schizophr Relat Psychoses; 2015 Jan; 8(4):205-8. PubMed ID: 23518784
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synthetic cannabinoids: Variety is definitely not the spice of life.
    Langford AM; Bolton JR
    J Forensic Leg Med; 2018 Oct; 59():36-38. PubMed ID: 30130700
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Clinical variants of psychoses in patients using synthetic cannabinoids (Spice)].
    Vinnikova MA; Skryabin VY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(8):23-26. PubMed ID: 32929920
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Death Associated With the Use of the Synthetic Cannabinoid ADB-FUBINACA.
    Shanks KG; Clark W; Behonick G
    J Anal Toxicol; 2016 Apr; 40(3):236-9. PubMed ID: 26755539
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Acute kidney injury associated with smoking synthetic cannabinoid.
    Buser GL; Gerona RR; Horowitz BZ; Vian KP; Troxell ML; Hendrickson RG; Houghton DC; Rozansky D; Su SW; Leman RF
    Clin Toxicol (Phila); 2014 Aug; 52(7):664-73. PubMed ID: 25089722
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hemorrhagic Soft Tissue Upper Airway Obstruction From Brodifacoum-Contaminated Synthetic Cannabinoid.
    Ross CH; Singh P; Simon EL
    J Emerg Med; 2019 Jul; 57(1):47-50. PubMed ID: 31078349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.